Vasopressin vs. norepinephrine for vasoplegic shock after cardiac surgery

Patients in the VANISH trial treated with vasopressin had a lower incidence of renal failure requiring hemodialysis. However, this was a secondary endpoint which seemed to contradict the primary endpoint (defined as a milder... read more

Vasopressin vs. norepinephrine for vasoplegic shock after cardiac surgery